Viewing Study NCT00693966


Ignite Creation Date: 2025-12-24 @ 4:18 PM
Ignite Modification Date: 2025-12-27 @ 5:14 PM
Study NCT ID: NCT00693966
Status: COMPLETED
Last Update Posted: 2016-09-16
First Post: 2008-06-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dose-Comparison Study to Evaluate the Safety and Immunogenicity of MEDI-517 (GSK 580299) in Healthy Adult Females
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module